Saturday, 3 October 2026European Markets

58% of EU accounts payable staff skip fraud checks under time pressure

Over half of accounts payable professionals in EU-regulated companies admit to occasionally bypassing verification steps due to time constraints, creating systemic fraud vulnerabilities. AI-driven automated verification systems can eliminate these shortcuts while matching or exceeding manual processing speeds. The gap between compliance requirements and operational reality exposes companies to both financial losses and regulatory penalties.

58% of EU accounts payable staff skip fraud checks under time pressure
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

58% of accounts payable professionals skip verification steps at least occasionally due to time pressure, according to PYMNTS research examining payment processing vulnerabilities.

This practice creates systemic fraud exposure in EU-regulated companies, where MiFID II, AMLD6, and corporate governance directives mandate robust internal controls. Manual verification processes force finance teams to choose between speed and compliance.

AI-driven automated verification eliminates this trade-off. Pelican Canada Inc., with over 25 years in payment processing and financial crime compliance, has demonstrated that AI systems can maintain 100% verification coverage while reducing processing time.

"In global money movement, a production-ready AI strategy relies on the quality of data," said Peter Cavicchia, highlighting the technical foundation required for automated controls.

EU companies face dual exposure from verification shortcuts. Financial losses from undetected fraud compound with regulatory penalties for inadequate controls. The European Banking Authority has increased scrutiny of payment processing controls following recent fraud cases.

AI automation addresses three critical points: invoice validation against purchase orders, vendor verification against approved lists, and payment authorization workflows. Traditional manual processes struggle with volume during month-end cycles, creating predictable vulnerability windows.

The compliance implications extend beyond immediate fraud prevention. Audit committees must now assess whether manual AP processes can credibly meet regulatory standards. External auditors are questioning the reliability of controls that depend on 100% human compliance under time pressure.

Implementation requires structured data feeds and integration with existing ERP systems. Companies with clean vendor master data and standardized invoice formats see faster deployment. The technology exists; adoption depends on finance leadership recognizing that current manual processes create unacceptable risk.

For EU-regulated entities, the question is no longer whether to automate AP verification, but how quickly they can implement systems that eliminate the human choice between speed and compliance.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com